StockData
Elevance Health, Inc. logo

Elevance Health, Inc.

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$413.60−6.47 (-1.54%)

Close on Nov 2, 2026Market cap $89.70BP/E 18.4Yield –

Elevance Health AFS Securities in Continuous Unrealized Loss Position by Year

AFS Securities in Continuous Unrealized Loss Position (≥ 12 Months) — Fair Value ($M)

Elevance Health AFS Securities in Continuous Unrealized Loss Position: $4,208M in FY2025, down 36.7% from a year earlier.

Latest, FY2025
4,208
Period ended Dec 31, 2025
Change on a year earlier
-36.7%
6,649 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below

Where the FY2025 figure comes from

“us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger (2025-12-31): 4,208,000,000.00”

Source: ELV 10-Q (XBRL us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss) ↗

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up AFS Securities in Continuous Unrealized Loss Position

Cite this data

StockData. (2026). Elevance Health AFS Securities in Continuous Unrealized Loss Position ($M), annual FY2022–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/inv-loss-pos-ge12m-fv

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.